Volume | 12 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Abbott Laboratories | ABT | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
105.19 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
4 | 12 | - | 89.674 - 115.83 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
03:07:58 | 3 | US$ 104.97 | USD |
Abbott Laboratories (ABT) Options Flow Summary
Abbott Laboratories Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
182.62B | 1.74B | - | 43.65B | 6.93B | 3.99 | 26.34 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Abbott Laboratories News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABT Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 102.20 | 105.505 | 101.35 | 104.16 | 7,045,648 | 2.99 | 2.93% |
1 Month | 94.57 | 105.505 | 92.43 | 100.32 | 5,956,051 | 10.62 | 11.23% |
3 Months | 102.05 | 105.505 | 89.674 | 97.25 | 6,006,128 | 3.14 | 3.08% |
6 Months | 104.06 | 115.83 | 89.674 | 101.51 | 5,269,487 | 1.13 | 1.09% |
1 Year | 106.90 | 115.83 | 89.674 | 103.75 | 5,120,584 | -1.71 | -1.6% |
3 Years | 107.72 | 142.60 | 89.674 | 112.27 | 5,331,836 | -2.53 | -2.35% |
5 Years | 70.59 | 142.60 | 61.61 | 101.18 | 5,578,070 | 34.60 | 49.02% |
Abbott Laboratories Description
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. |